Private equity is clustering into radiology and specialized industrial infrastructure

Private equity is moving capital into two distinct pockets: radiology assets and specialized industrial infrastructure. The pattern is clear enough to name.

PE Hub reports five separate radiology transactions in recent weeks, with Archimed, Grovecourt, and Kain Capital all committing capital to imaging and diagnostic platforms. Warburg Pincus separately acquired Network Plus, a radiology-adjacent play. The cluster is not coincidental. Radiology infrastructure is defensible, capital-intensive, and resistant to commoditization. It sits downstream of hospital budget pressure and upstream of diagnostic demand that does not compress in a downturn.

On the industrial side, Norwest Venture Partners invested in East Range Group, a high-purity water systems firm serving semiconductor, pharmaceutical, and data center operators. The thesis is similar: specialized infrastructure that requires domain expertise, carries switching costs, and benefits from secular tailwinds in chips, biotech, and AI compute. Latticework and Edgehill backed the acquisition of CDMO brands in the same window, another nod to pharma infrastructure that is hard to replicate and expensive to replace.

The common thread is durability. These are not software multiples or consumer roll-ups. They are long-cycle, high-switching-cost assets that generate predictable cash in environments where predictability is being repriced. The capital is moving toward businesses that are harder to build than they are to buy, and harder to displace once installed.

Watch whether this clustering accelerates or whether these are isolated reads. If radiology and specialized industrial continue to draw multiple simultaneous bids, the pattern becomes a positioning shift. If it thins out, it was opportunistic. The next eight weeks will clarify which.